We find that IFNλ serves as a better marker of STING pathway activation in epithelial cancer cells than IFNβ, and that cancer cell-specific downregulation of IFNLR1 prevents autocrine and paracrine IFNλ signaling. The gene discussed is IFNLR1; the disease is cancer.